In our study, the Foxp3+ SIs in breast cancer PTs were significantly higher than those in benign diseases and normal adjacent tissues, but lower than those in the TDLNs which showed the same pattern as the IDO+SIs. This evidence concerns the gene IDO1 and breast carcinoma.